Show simple item record

dc.contributor.authorChilcott, Robert
dc.contributor.authorJenner, J.
dc.contributor.authorHotchkiss, S. A. M.
dc.contributor.authorRice, P.
dc.date.accessioned2014-01-16T10:30:31Z
dc.date.available2014-01-16T10:30:31Z
dc.date.issued2002
dc.identifier.citationChilcott , R , Jenner , J , Hotchkiss , S A M & Rice , P 2002 , ' Evaluation of barrier creams against sulphur mustard ' , Skin Pharmacology and Applied Skin Physiology , vol. 15 , no. 4 , pp. 225-235 . https://doi.org/10.1159/000065969
dc.identifier.issn1422-2868
dc.identifier.urihttp://hdl.handle.net/2299/12555
dc.description.abstractThe purpose of this study was to assess the effectiveness of a range of passive and reactive barrier cream formulations against the chemical war-fare agent sulphur mustard (SM) using an in vitro diffusion cell system containing human skin. In general, proprietary formulations were relatively effective under occluded conditions, but ineffective under unoccluded conditions. For example, SM skin absorption rates through occluded control and Stokoderm(R) pre-treated skin were 538 +/- 193 and 200 +/- 51 mug(.)cm(-2.)h(-1), respectively (p < 0.05). Under unoccluded conditions, control and Stokoderm pre-treated skin absorption rates were 4.41 +/- 1.90 and 36.84 +/- 15.19 mug(.)cm(-2.)h(-1) p < 0.05). Novel (perfluorinated barrier creams were generally more effective under unoccluded conditions; pre-treatment with one formulation led to an 18-fold reduction in skin absorption rate and reduced the total amount of SM penetrated by 95% of the applied dose. Several proprietary formulations also had adverse effects on the effectiveness of the skin decontaminant fuller's earth. The rate (Jss) and total amount (percentage of dose) of SM absorbed through the skin were deemed to be independent parameters of barrier cream performance. These data indicate that (1) perceived conditions of use, (2) compatibility with existing protective equipment and (3) the rate and extent of SM skin absorption must all be taken into account when evaluating barrier creams in vitro. Copyright (C) 2002 S. Karger AG, Basel.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofSkin Pharmacology and Applied Skin Physiology
dc.subjectBarrier creams
dc.subjectdecontaminants
dc.subjectsulphur mustard
dc.subjectin vitro
dc.subjecthuman skin
dc.subjectSULFUR MUSTARD
dc.subjectHUMAN-SKIN
dc.subjectPERCUTANEOUS ABSORPTION
dc.subjectIN-VITRO
dc.subjectDECONTAMINATION
dc.subjectPIG
dc.subjectDERMATITIS
dc.subjectWATER
dc.subjectVIVO
dc.titleEvaluation of barrier creams against sulphur mustarden
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionCentre for Research into Topical Drug Delivery and Toxicology
dc.contributor.institutionPharmaceutics
dc.contributor.institutionToxicology
dc.contributor.institutionCentre for Applied Clinical, Health and Care Research (CACHE)
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1159/000065969
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record